Back to top

Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)

In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Nuvectis Pharma, with a price target of $30.00. Rahman cover...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nuvectis Pharma, Inc. (NVCT)